Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 308

1.

[Vestibular schwannoma as possible cause for auditory hallucinations in a woman with schizophrenia].

Urbahnke J, Rohde M, Rasmussen B, Krone W, Jafari AA.

Ugeskr Laeger. 2019 Nov 11;181(46). pii: V08190465. Danish.

PMID:
31791465
2.

The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.

Aparicio-Siegmund S, Garbers Y, Flynn CM, Waetzig GH, Gouni-Berthold I, Krone W, Berthold HK, Laudes M, Rose-John S, Garbers C.

Am J Physiol Endocrinol Metab. 2019 Aug 1;317(2):E411-E420. doi: 10.1152/ajpendo.00166.2019. Epub 2019 Jun 25.

PMID:
31237452
3.

Obstructive hydrocephalus caused by colloid cyst presenting as a schizophrenia-like psychosis.

Højlund M, Hansen P, Krone W, Høgh L.

BMJ Case Rep. 2018 Jun 8;2018. pii: bcr-2017-223037. doi: 10.1136/bcr-2017-223037.

PMID:
29884711
4.

[A stroke mimic: hemichorea associated with non-ketotic hyperglycaemia].

Hald SM, Krone W, Minhas ZA, Gaist D.

Ugeskr Laeger. 2017 May 8;179(19). pii: V01170006. Danish.

PMID:
28504621
5.

[Pneumatosis intestinalis].

Krone W, Bloch K.

Ugeskr Laeger. 2015 Jun 22;177(26):1284. Danish. No abstract available.

PMID:
26099181
6.

IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans.

Müller N, Schulte DM, Türk K, Freitag-Wolf S, Hampe J, Zeuner R, Schröder JO, Gouni-Berthold I, Berthold HK, Krone W, Rose-John S, Schreiber S, Laudes M.

J Lipid Res. 2015 May;56(5):1034-42. doi: 10.1194/jlr.P052209. Epub 2015 Feb 21.

7.

[Incidental finding: elevated TSH level].

Faust M, Krone W.

Internist (Berl). 2014 Oct;55(10):1149-56. doi: 10.1007/s00108-014-3589-4. German.

PMID:
25204533
8.

[Increased BMI: Which effect do additional risk factors have? - Obese patients: Additional risk factors are highly involved].

Krone W.

Dtsch Med Wochenschr. 2014 May;139(21):1092. doi: 10.1055/s-0033-1353904. Epub 2014 May 7. German. No abstract available.

PMID:
24806221
9.

[Mediterranean diet for primary prevention of cardiovascular diseases : Prevención-con-Dieta-Mediterránea (PREDIMED) Study].

Krone W, Nitschmann S.

Internist (Berl). 2014 May;55(5):607-8. doi: 10.1007/s00108-014-3497-7. German. No abstract available.

PMID:
24733638
10.

Effects of lipid-lowering drugs on high-density lipoprotein subclasses in healthy men-a randomized trial.

Berthold HK, Rizzo M, Spenrath N, Montalto G, Krone W, Gouni-Berthold I.

PLoS One. 2014 Mar 24;9(3):e91565. doi: 10.1371/journal.pone.0091565. eCollection 2014.

11.

Caloric restriction increases serum testosterone concentrations in obese male subjects by two distinct mechanisms.

Schulte DM, Hahn M, Oberhäuser F, Malchau G, Schubert M, Heppner C, Müller N, Güdelhöfer H, Faust M, Krone W, Laudes M.

Horm Metab Res. 2014 Apr;46(4):283-6. doi: 10.1055/s-0033-1358678. Epub 2013 Nov 6.

PMID:
24198220
12.

Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo.

Gouni-Berthold I, Berthold HK, Huh JY, Berman R, Spenrath N, Krone W, Mantzoros CS.

PLoS One. 2013 Sep 2;8(9):e72858. doi: 10.1371/journal.pone.0072858. eCollection 2013.

13.

Selenium and hypertension: do we need to reconsider selenium supplementation in cancer patients?

Gouni-Berthold I, Michalke B, Krone W, Guallar E, Berthold HK.

J Hypertens. 2013 May;31(5):1050-2. doi: 10.1097/HJH.0b013e32835efecb. No abstract available.

PMID:
23552030
14.

Neuronal overexpression of insulin receptor substrate 2 leads to increased fat mass, insulin resistance, and glucose intolerance during aging.

Zemva J, Udelhoven M, Moll L, Freude S, Stöhr O, Brönneke HS, Drake RB, Krone W, Schubert M.

Age (Dordr). 2013 Oct;35(5):1881-97. doi: 10.1007/s11357-012-9491-x. Epub 2012 Nov 17.

15.

Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein.

Berthold HK, Berneis K, Mantzoros CS, Krone W, Gouni-Berthold I.

Scand Cardiovasc J Suppl. 2013 Feb;47(1):20-7. doi: 10.3109/14017431.2012.734635. Epub 2012 Oct 18.

PMID:
23013513
16.

Influence of serum selenium concentrations on hypertension: the Lipid Analytic Cologne cross-sectional study.

Berthold HK, Michalke B, Krone W, Guallar E, Gouni-Berthold I.

J Hypertens. 2012 Jul;30(7):1328-35. doi: 10.1097/HJH.0b013e32835414df.

PMID:
22573120
17.

Chronic peripheral hyperinsulinemia has no substantial influence on tau phosphorylation in vivo.

Becker K, Freude S, Zemva J, Stöhr O, Krone W, Schubert M.

Neurosci Lett. 2012 May 16;516(2):306-10. doi: 10.1016/j.neulet.2012.04.022. Epub 2012 Apr 12.

PMID:
22521314
18.

Weight loss due to a very low calorie diet differentially affects insulin sensitivity and interleukin-6 serum levels in nondiabetic obese human subjects.

Oberhauser F, Schulte DM, Faust M, Güdelhöfer H, Hahn M, Müller N, Neumann K, Krone W, Laudes M.

Horm Metab Res. 2012 Jun;44(6):465-70. doi: 10.1055/s-0032-1306341. Epub 2012 Mar 21.

PMID:
22438213
19.

Complete failure of insulin-transmitted signaling, but not obesity-induced insulin resistance, impairs respiratory chain function in muscle.

Franko A, von Kleist-Retzow JC, Böse M, Sanchez-Lasheras C, Brodesser S, Krut O, Kunz WS, Wiedermann D, Hoehn M, Stöhr O, Moll L, Freude S, Krone W, Schubert M, Wiesner RJ.

J Mol Med (Berl). 2012 Oct;90(10):1145-60. doi: 10.1007/s00109-012-0887-y. Epub 2012 Mar 13.

PMID:
22411022
20.

Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects.

Schulte DM, Müller N, Neumann K, Oberhäuser F, Faust M, Güdelhöfer H, Brandt B, Krone W, Laudes M.

PLoS One. 2012;7(2):e32437. doi: 10.1371/journal.pone.0032437. Epub 2012 Feb 23.

21.

Novel therapeutic approaches to CNS metastases in malignant phaeochromocytomas - case report of the first patient with a large cystic CNS lesion.

Schulte DM, Faust M, Schmidt M, Ruge MI, Grau S, Blau T, Kocher M, Krone W, Laudes M.

Clin Endocrinol (Oxf). 2012 Aug;77(2):332-4. doi: 10.1111/j.1365-2265.2012.04354.x. No abstract available.

PMID:
22288775
22.

Neuron-specific deletion of a single copy of the insulin-like growth factor-1 receptor gene reduces fat accumulation during aging.

Freude S, Schilbach K, Hettich MM, Brönneke HS, Zemva J, Krone W, Schubert M.

Horm Metab Res. 2012 Feb;44(2):99-104. doi: 10.1055/s-0031-1298018. Epub 2011 Dec 23.

PMID:
22198814
23.

Central FoxO3a and FoxO6 expression is down-regulated in obesity induced diabetes but not in aging.

Zemva J, Schilbach K, Stöhr O, Moll L, Franko A, Krone W, Wiesner RJ, Schubert M.

Exp Clin Endocrinol Diabetes. 2012 Jun;120(6):340-50. doi: 10.1055/s-0031-1297970. Epub 2011 Dec 20.

PMID:
22187289
24.

Lipid lowering in patients with chronic kidney disease: a SHARP turn in the wrong direction?

Berthold HK, Krone W, Erdmann E, Gouni-Berthold I.

Eur J Cardiovasc Prev Rehabil. 2011 Dec;18(6):858-61. doi: 10.1177/1741826711423116.

PMID:
22087046
25.

Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease.

Stöhr O, Schilbach K, Moll L, Hettich MM, Freude S, Wunderlich FT, Ernst M, Zemva J, Brüning JC, Krone W, Udelhoven M, Schubert M.

Age (Dordr). 2013 Feb;35(1):83-101. doi: 10.1007/s11357-011-9333-2. Epub 2011 Nov 6.

26.

The whey fermentation product malleable protein matrix decreases TAG concentrations in patients with the metabolic syndrome: a randomised placebo-controlled trial.

Gouni-Berthold I, Schulte DM, Krone W, Lapointe JF, Lemieux P, Predel HG, Berthold HK.

Br J Nutr. 2012 Jun;107(11):1694-706. doi: 10.1017/S0007114511004843.

PMID:
21996130
27.

Association between the interleukin-6 promoter polymorphism -174G/C and serum lipoprotein(a) concentrations in humans.

Berthold HK, Laudes M, Krone W, Gouni-Berthold I.

PLoS One. 2011;6(9):e24719. doi: 10.1371/journal.pone.0024719. Epub 2011 Sep 14.

28.

Disease management programs in type 2 diabetes: quality of care.

Berthold HK, Bestehorn KP, Jannowitz C, Krone W, Gouni-Berthold I.

Am J Manag Care. 2011 Jun;17(6):393-403.

29.

Insulin receptor substrate-1 and -2 mediate resistance to glucose-induced caspase-3 activation in human neuroblastoma cells.

Stöhr O, Hahn J, Moll L, Leeser U, Freude S, Bernard C, Schilbach K, Markl A, Udelhoven M, Krone W, Schubert M.

Biochim Biophys Acta. 2011 May;1812(5):573-80. doi: 10.1016/j.bbadis.2011.02.006. Epub 2011 Feb 24.

30.

Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans.

Bilkovski R, Schulte DM, Oberhauser F, Mauer J, Hampel B, Gutschow C, Krone W, Laudes M.

Int J Obes (Lond). 2011 Nov;35(11):1450-4. doi: 10.1038/ijo.2011.6. Epub 2011 Feb 1.

PMID:
21285942
31.

The whey fermentation product malleable protein matrix decreases triglyceride concentrations in subjects with hypercholesterolemia: a randomized placebo-controlled trial.

Berthold HK, Schulte DM, Lapointe JF, Lemieux P, Krone W, Gouni-Berthold I.

J Dairy Sci. 2011 Feb;94(2):589-601. doi: 10.3168/jds.2010-3115.

32.

Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases.

Schultz O, Oberhauser F, Saech J, Rubbert-Roth A, Hahn M, Krone W, Laudes M.

PLoS One. 2010 Dec 13;5(12):e14328. doi: 10.1371/journal.pone.0014328.

33.

Atherosclerotic disease location and disparities in the control and treatment of cardiovascular risk factors in patients with Type 2 diabetes.

Berthold HK, Bestehorn KP, Krone W, Gouni-Berthold I.

Diabet Med. 2010 Mar;27(3):303-8. doi: 10.1111/j.1464-5491.2010.02952.x.

PMID:
20536493
34.

Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial.

Berneis K, Rizzo M, Berthold HK, Spinas GA, Krone W, Gouni-Berthold I.

Eur Heart J. 2010 Jul;31(13):1633-9. doi: 10.1093/eurheartj/ehq181. Epub 2010 Jun 6.

35.

Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndrome.

Krone W, Hanefeld M, Meyer HF, Jung T, Bartlett M, Yeh CM, Rajman I, Prescott MF, Dole WP.

J Hum Hypertens. 2011 Mar;25(3):186-95. doi: 10.1038/jhh.2010.38. Epub 2010 Apr 8.

PMID:
20376075
36.

Dipeptidyl-peptidase 4 and attractin expression is increased in circulating blood monocytes of obese human subjects.

Laudes M, Oberhauser F, Schulte DM, Schilbach K, Freude S, Bilkovski R, Schulz O, Faust M, Krone W.

Exp Clin Endocrinol Diabetes. 2010 Aug;118(8):473-7. doi: 10.1055/s-0030-1249014. Epub 2010 Mar 2.

PMID:
20198559
37.

Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.

Laudes M, Oberhauser F, Schulte DM, Freude S, Bilkovski R, Mauer J, Rappl G, Abken H, Hahn M, Schulz O, Krone W.

Horm Metab Res. 2010 Apr;42(4):268-73. doi: 10.1055/s-0029-1243638. Epub 2010 Jan 20.

PMID:
20091460
38.

Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes.

Bilkovski R, Schulte DM, Oberhauser F, Gomolka M, Udelhoven M, Hettich MM, Roth B, Heidenreich A, Gutschow C, Krone W, Laudes M.

J Biol Chem. 2010 Feb 26;285(9):6170-8. doi: 10.1074/jbc.M109.054338. Epub 2009 Dec 23.

39.

Influence of ghrelin gene polymorphisms on hypertension and atherosclerotic disease.

Berthold HK, Giannakidou E, Krone W, Trégouët DA, Gouni-Berthold I.

Hypertens Res. 2010 Feb;33(2):155-60. doi: 10.1038/hr.2009.194. Epub 2009 Dec 11.

PMID:
20010782
40.

Neuronal insulin receptor substrate 2 (IRS2) expression is regulated by ZBP89 and SP1 binding to the IRS2 promoter.

Udelhoven M, Pasieka M, Leeser U, Krone W, Schubert M.

J Endocrinol. 2010 Feb;204(2):199-208. doi: 10.1677/JOE-09-0266. Epub 2009 Oct 29.

PMID:
19875459
41.

Identification of a region in the human IRS2 promoter essential for stress induced transcription depending on SP1, NFI binding and ERK activation in HepG2 cells.

Udelhoven M, Leeser U, Freude S, Hettich MM, Laudes M, Schnitker J, Krone W, Schubert M.

J Mol Endocrinol. 2010 Feb;44(2):99-113. doi: 10.1677/JME-08-0182. Epub 2009 Sep 15.

PMID:
19755487
42.

Vitamin D and cardiovascular disease.

Gouni-Berthold I, Krone W, Berthold HK.

Curr Vasc Pharmacol. 2009 Jul;7(3):414-22. Review.

PMID:
19601865
43.

Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease.

Freude S, Hettich MM, Schumann C, Stöhr O, Koch L, Köhler C, Udelhoven M, Leeser U, Müller M, Kubota N, Kadowaki T, Krone W, Schröder H, Brüning JC, Schubert M.

FASEB J. 2009 Oct;23(10):3315-24. doi: 10.1096/fj.09-132043. Epub 2009 Jun 1.

PMID:
19487308
44.

Patterns and predictors of statin prescription in patients with type 2 diabetes.

Berthold HK, Gouni-Berthold I, Böhm M, Krone W, Bestehorn KP.

Cardiovasc Diabetol. 2009 May 13;8:25. doi: 10.1186/1475-2840-8-25.

45.

Comparison of phenotypes in male and female individuals of a new family with Dunnigan type of familial partial lipodystrophy due to a lamin A/C R482W mutation.

Laudes M, Oberhauser F, Walgenbach K, Schubert M, Schulte DM, Faust M, Krone W.

Horm Metab Res. 2009 May;41(5):414-7. doi: 10.1055/s-0028-1128138. Epub 2009 Feb 9. No abstract available.

PMID:
19204888
46.

Human fetal adiponectin and retinol-binding protein (RBP)-4 levels in relation to birth weight and maternal obesity.

Laudes M, Oberhauser F, Bilkovski R, Schubert M, Udelhoven M, Wassmer G, Roth B, Krone W.

Exp Clin Endocrinol Diabetes. 2009 Mar;117(3):146-9. doi: 10.1055/s-0028-1100379. Epub 2008 Dec 3.

PMID:
19053019
47.

Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism.

Minnemann T, Schubert M, Freude S, Hübler D, Gouni-Berthold I, Schumann C, Christoph A, Oettel M, Ernst M, Mellinger U, Krone W, Jockenhövel F.

J Endocrinol Invest. 2008 Aug;31(8):718-23.

PMID:
18852533
48.

The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes.

Berthold HK, Giannakidou E, Krone W, Mantzoros CS, Gouni-Berthold I.

Clin Chim Acta. 2009 Jan;399(1-2):112-6. doi: 10.1016/j.cca.2008.09.022. Epub 2008 Sep 25.

PMID:
18848536
49.

IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination.

Freude S, Leeser U, Müller M, Hettich MM, Udelhoven M, Schilbach K, Tobe K, Kadowaki T, Köhler C, Schröder H, Krone W, Brüning JC, Schubert M.

J Neurochem. 2008 Nov;107(4):907-17. doi: 10.1111/j.1471-4159.2008.05631.x. Epub 2008 Sep 18.

50.

Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth.

Klöting N, Koch L, Wunderlich T, Kern M, Ruschke K, Krone W, Brüning JC, Blüher M.

Diabetes. 2008 Aug;57(8):2074-82. doi: 10.2337/db07-1538. Epub 2008 Apr 28.

Supplemental Content

Support Center